UK needs a devices industry leader to avoid "pharma drift"
This article was originally published in Clinica
Executive Summary
The UK medical devices industry is calling for the clear identification within the Medicines and Healthcare products Regulatory Agency (MHRA) of an individual who should be responsible for continuing to fight at European level for "commonsense and pragmatic solutions" to medical device regulatory problems, according to Malcolm Carlisle, group managing director of Eschmann Holdings.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.